JamBot Logo
1-90 of about 90 matches for site:www.patentsencyclopedia.com decrease respiratory
https://www.patentsencyclopedia.com/app/20220296839
which manufacturability and usability of respiratory masks are improved. A respiratory mask is disclosed for
https://www.patentsencyclopedia.com/app/20220280113
percent of ribcage excursion, tidal volume, minute volume, inhale airflow velocity, exhale airflow velocity, respiratory rhythm, and respiratory
https://www.patentsencyclopedia.com/app/20220281846
0015] The improvement in respiratory function may be selected from a decrease in the
https://www.patentsencyclopedia.com/app/20220280450
PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED RESPIRATORY INFECTIONS - Patent application Inventors list Assignees list
https://www.patentsencyclopedia.com/app/20220297039
biological contaminants can also trigger allergic reactions, including asthma. Health problems caused by biological contaminants include respiratory symptoms, such sneezing, watery
https://www.patentsencyclopedia.com/app/20220282739
of conditioned gas for a future respiratory cycle, electronic control circuitry can decrease the amount
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_8
may be caused by coronaviruses, including severe acute respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus. N-Butyloxycarbonyl
https://www.patentsencyclopedia.com/app/20220296799
region in which the third braiding angle is configured to gradually decrease from the first
https://www.patentsencyclopedia.com/app/20220233472
a mixing equipment. 10. A drug for auxiliary treatment of respiratory diseases of livestock
https://www.patentsencyclopedia.com/app/20220296847
a blood pressure sensor, a pulse oximetry (SpO.sub.2) sensor, a respiratory rate monitor, a
https://www.patentsencyclopedia.com/app/20220233987
well-established mechanism for disinfecting against various viruses, bacteria, fungi, etc. that cause acute respiratory syndromes thereby helping decrease
https://www.patentsencyclopedia.com/app/20220296836
of respiration and sleep therapy for supplying a patient with respiratory gas by means of
https://www.patentsencyclopedia.com/app/20220233856
a useful way to treat acute medical conditions, such as trauma, hemorrhaging, shock, acute respiratory distress syndrome (ARDS), severe
https://www.patentsencyclopedia.com/app/20220298477
A method for treating or preventing radiation-induced lung injury, acute lung injury, acute respiratory distress syndrome, idiopathic pulmonary
https://www.patentsencyclopedia.com/app/20220280556
of a composition comprising lignosulfonate for attenuation of severe acute respiratory syndrome coronavirus 2 (SARS
https://www.patentsencyclopedia.com/app/20220280521
with roseoflavin (RoF), and a relative survival rate was calculated assuming that mitochondrial respiratory chain activity corresponded to
https://www.patentsencyclopedia.com/hgl/02-17-22/02-17-22_8
based assays. Our study also demonstrates that brazilin and theaflavin-3, 3′-digallate, curcumin, decrease the activity
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_27
inventors show that antisense oligonucleotides masking the secretory polyadenylation signal induce a decrease in the
https://www.patentsencyclopedia.com/inventor/jeffrey-e-stahmann-ramsey...
the invention are related to methods and devices for respiratory or cardiac disease detection
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_4
in a second rotation direction, opposite to the first rotation direction, will decrease the gap
https://www.patentsencyclopedia.com/hgl/08-04-22/08-04-22_10
i) to overexpress BLIMP1 and/or (ii) to knock-out or decrease expression of BCL6
https://www.patentsencyclopedia.com/app/20220296832
according to claim 1, where the patient connector is a respiratory connector. 15. The
https://www.patentsencyclopedia.com/inventor/dennis-j-rivet-portsmouth...
utility modules comprising a first module operable in a digestive or respiratory tract to engage
https://www.patentsencyclopedia.com/app/20090269329
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20090271213
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20090271010
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20090271120
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20220296550
of one or more embodiments provided by the present disclosure is to decrease a length
https://www.patentsencyclopedia.com/app/20220282279
or MERS-CoV), ebola virus, Marburg virus, human parainfluenza virus 1, measles virus, mumps virus, human respiratory syncytial virus, vesicular stomatitis
https://www.patentsencyclopedia.com/app/20220296544
demonstrated its ability as an antiviral agent against hepatitis B virus, Epstein Barr virus, severe acute respiratory syndrome (SARS), coronavirus, Japanese
https://www.patentsencyclopedia.com/app/20220234703
tanks, the gas volume used in every breath and the respiratory rate. Typical breathing volumes
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_8
09-08 20220280450 PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED RESPIRATORY INFECTIONS - The present
https://www.patentsencyclopedia.com/app/20220235360
inventors show that antisense oligonucleotides masking the secretory polyadenylation signal induce a decrease in the
https://www.patentsencyclopedia.com/app/20220282068
Moreover, there has been some modeling studies that suggest the sulfate-based aerosols could decrease rainfall in Asia
https://www.patentsencyclopedia.com/hgl/09-01-22/09-01-22_10
vectors, pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a
https://www.patentsencyclopedia.com/app/20220233468
i.e., severe acute respiratory syndrome (SARS) in 2002 to 2003, Middle East respiratory syndrome (MERS) in
https://www.patentsencyclopedia.com/hgl/09-01-22/09-01-22_11
09-01 20220273901 OUTLET CONNECTION ASSEMBLY - A connection assembly for a respiratory therapy system, comprising: an
https://www.patentsencyclopedia.com/app/20220280561
disorders caused by SMARCAL1 mutations, neurological disorders caused by KIF1A mutations, Huntington's disease, SMA with respiratory distress and Charcot
https://www.patentsencyclopedia.com/app/20220233214
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220238197
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220233254
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220233252
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_23
at which the bacterium is grown, it is feasible to increase or decrease the amount
https://www.patentsencyclopedia.com/app/20220280320
failure, and venous disease. Obesity can also cause orthopedic problems, skin problems and respiratory difficulties. [0007] A
https://www.patentsencyclopedia.com/app/20220280067
devices for capturing the CO.sub.2 fraction in the respiratory gas through infrared spectroscopy
https://www.patentsencyclopedia.com/app/20220282221
iFGEs and iHTNs. Consequently, EDC treatment decreased maximal mitochondrial respiration and spare respiratory capacity in iFGEs
https://www.patentsencyclopedia.com/app/20090271008
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20220235361
pathological state is cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease (COPD), asthma, respiratory tract infections, lung carcinoma
https://www.patentsencyclopedia.com/app/20220233488
mucosal membranes/tissues, optionally, tissues of the lung and the respiratory tract; and cardiovascular
https://www.patentsencyclopedia.com/app/20220233191
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220238216
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220233102
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220282218
Epstein-Barr virus (EBV), cytomegalovirus (CMV), and herpes simplex virus, as well as by respiratory viruses such as respiratory
https://www.patentsencyclopedia.com/app/20220233686
epitopes aimed by in-silica tools can result in an increase or decrease, in the
https://www.patentsencyclopedia.com/app/20220280467
consisting of cystic fibrosis, pneumonia, viral pulmonary infection, bacterial pulmonary infection, fungal pulmonary infection, acute respiratory distress syndrome, asthma, chronic
https://www.patentsencyclopedia.com/app/20220236249
of sputum characteristics. BACKGROUND OF THE INVENTION [0003] Many patients with chronic respiratory diseases, such as, for
https://www.patentsencyclopedia.com/app/20220283278
breathing, such that different subsets of the ultrasound data are acquired under different respiratory motion conditions. 8. The
https://www.patentsencyclopedia.com/app/20220235393
s). For example, 4 log.sub.10 of porcine reproductive and respiratory syndrome (PRRS) virus, a
https://www.patentsencyclopedia.com/app/20220285031
test may be, for example, a brain wave test, a respiratory function test, a
https://www.patentsencyclopedia.com/app/20220280062
The technology can be used to detect viral protein, such as severe acute respiratory syndrome coronavirus 2 (SARS
https://www.patentsencyclopedia.com/app/20210322690
OT treatment condition in comparison to both Placebo (p=0.011; mean decrease=17%, SE decrease 6
https://www.patentsencyclopedia.com/app/20220280475
used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase
https://www.patentsencyclopedia.com/inventor/mcallister-us-5/
the current. The processor can output a command specifying an increase or decrease in the
https://www.patentsencyclopedia.com/app/20220096763
its anterior part with transitional epithelium, with a gradual transition posterior to respiratory epithelium. The nasal
https://www.patentsencyclopedia.com/app/20090101838
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090101846
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090101841
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090104179
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090104113
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20220280507
rate, decreased blood pressure, urinary and fecal incontinence, possibly deaths due to respiratory and circulatory
https://www.patentsencyclopedia.com/app/20220235313
enzootic pneumonia and is a factor in the porcine respiratory disease complex (PRDC) along
https://www.patentsencyclopedia.com/app/20220282257
amount effective increase one or more of lipolysis, fatty acid oxidation, lipid metabolism or decrease lipogenesis in adipose
https://www.patentsencyclopedia.com/app/20220233539
pancreas; retroperitoneum; peritoneum, omentum, and mesentery; other digestive); cancers of the respiratory system (nasal cavity, middle
https://www.patentsencyclopedia.com/app/20220233540
pancreas; retroperitoneum; peritoneum, omentum, and mesentery; other digestive); cancers of the respiratory system (nasal cavity, middle
https://www.patentsencyclopedia.com/app/20220236277
urine, tears, milk, lymph fluid, synovial fluid, bronchoalveolar lavage, amniotic fluid, saliva, ocular fluid, ascites, or respiratory droplets. [0020] The
https://www.patentsencyclopedia.com/app/20220280682
with medical devices or blood product transfusions. Three major sites of HAIs are bloodstream, respiratory tract, and urinary
https://www.patentsencyclopedia.com/app/20220282962
heart rale-based modulation. Sensors inside the pacemaker, such as accelerometers and respiratory movement detectors, regulate pacemaker
https://www.patentsencyclopedia.com/app/20220233114
brain and heart, and continued low oxygen levels may lead to respiratory or cardiac arrest. In
https://www.patentsencyclopedia.com/app/20220236287
even death. The varying symptomatology, even shared with other acute cardiothoracic and respiratory diseases, can delay the
https://www.patentsencyclopedia.com/app/20220280513
benefit of the present invention can also, or alternatively, be a decrease in the
https://www.patentsencyclopedia.com/app/20220233163
rate and heart rhythm, chest motion sensors to monitor the respiratory rate, and thermometer
https://www.patentsencyclopedia.com/app/20220233190
FIGS. 3E and 3F. [0031] In order to avoid or decrease the possibility
https://www.patentsencyclopedia.com/inventor/yujiro-7/
values, body temperature, the degree of anger or anxiety, and respiratory rate. 01-03-2013
https://www.patentsencyclopedia.com/app/20220281951
also by use of a K74A mutation. Other mutations that caused an overall decrease in ligand
https://www.patentsencyclopedia.com/app/20220280526
such as high costs, difficult application routes and systemic side effects such as upper respiratory tract infections, see Wasilewska
https://www.patentsencyclopedia.com/app/20220280263
fraught with numerous potential adverse side effects such as overdose, suppression of the respiratory drive, constipation, and
https://www.patentsencyclopedia.com/app/20090149708
may be surgically or otherwise provided where desired within a bodily system (e.g., digestive, respiratory, or circulatory system(s
https://www.patentsencyclopedia.com/app/20220279797
demonstrated against the hepatitis A and C virus and respiratory syncytial virus (RSV). [0010
https://www.patentsencyclopedia.com/app/20220236261
scanning cannot detect asymptomatic infections, nor can it distinguish the novel coronavirus from other respiratory illnesses. Swab-type coronavirus
https://www.patentsencyclopedia.com/app/20220232874
relatedness, object recognition [0006] 3. Support social-emotional development [0007] 4. Support better sleep [0008] 5. Decrease stress, reduce crying, colic